Terms: = Sarcomas AND TCF12, HEB, 6938, ENSG00000140262, HsT17266, HTF4 AND Treatment
3 results:
1. Revealing the pharmacological effects of Remodelin against osteosarcoma based on network pharmacology, acRIP-seq and experimental validation.
Gao J; Xu P; Wang F; Zhang W; Min M; Urba R; Fan L
Sci Rep; 2024 Feb; 14(1):3577. PubMed ID: 38347067
[TBL] [Abstract] [Full Text] [Related]
2. Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group.
Paioli A; Stacchiotti S; Campanacci D; Palmerini E; Frezza AM; Longhi A; Radaelli S; Donati DM; Beltrami G; Bianchi G; Barisella M; Righi A; Benini S; Fiore M; Picci P; Gronchi A
Ann Surg Oncol; 2021 Feb; 28(2):1142-1150. PubMed ID: 32572850
[TBL] [Abstract] [Full Text] [Related]
3. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract] [Full Text] [Related]
